Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy

BACKGROUND: We previously developed a robust prognostic model (GS model) to predict the survival outcome of patients with advanced pancreatic cancer (APC) receiving palliative chemotherapy with gemcitabine plus S‐1 (GS). This study aimed to validate the application of the GS model in APC patients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Pei‐Wei, Chang, Ching‐Fu, Hung, Chia‐Yen, Hsueh, Shun‐Wen, Chang, Pei‐Hung, Yeh, Kun‐Yun, Chen, Jen‐Shi, Chen, Yen‐Yang, Lu, Chang‐Hsien, Hung, Yu‐Shin, Chou, Wen‐Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745849/
https://www.ncbi.nlm.nih.gov/pubmed/31385456
http://dx.doi.org/10.1002/cam4.2483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745849/
https://www.ncbi.nlm.nih.gov/pubmed/31385456
http://dx.doi.org/10.1002/cam4.2483

Ejemplares similares